35493933|t|Alterations of Striatal Subregions in a Prion Protein Gene V180I Mutation Carrier Presented as Frontotemporal Dementia With Parkinsonism.
35493933|a|Objective: To explore the roles of striatal subdivisions in the pathogenesis of frontotemporal dementia with parkinsonism (FTDP) in a patient resulting from prion protein gene (PRNP) mutation. Methods: This patient received clinical interviews and underwent neuropsychological assessments, genetic testing, [18F]-fluorodeoxyglucose positron emission tomography ([18F]-FDG PET)/MRI, and [18F]-dihydrotetrabenazine positron emission tomography ([18F]-DTBZ PET)/CT. Region-of-interest analysis was conducted concerning metabolism, and dopamine transport function between this patient and 12 controls, focusing on the striatum subregions according to the Oxford-GSK-Imanova Striatal Connectivity Atlas. Results: A 64-year-old man initially presented with symptoms of motor dysfunction and subsequently behavioral and personality changes. FTDP was initially suspected. Sequence analysis disclosed a valine to isoleucine at codon 180 in PRNP. Compared to controls, this patient had a severe reduction (> 2SD) of standard uptake value ratio (SUVR) in the limbic and executive subregions but relative retention of metabolism in rostral motor and caudal motor subregions using [18F]-FDG PET/MRI, and the SUVR decreased significantly across the striatal in [18F]-DTBZ PET/CT, especially in the rostral motor and caudal motor subregions. Conclusion: The alteration of frontal striatal loops may be involved in cognitive impairment in FTDP, and the development of parkinsonism in FTDP may be primarily due to the involvement of the presynaptic nigrostriatal loops in PRNP V180I mutation.
35493933	40	58	Prion Protein Gene	Gene	5621
35493933	59	64	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
35493933	95	136	Frontotemporal Dementia With Parkinsonism	Disease	MESH:D057180
35493933	218	259	frontotemporal dementia with parkinsonism	Disease	MESH:D057180
35493933	261	265	FTDP	Disease	MESH:D057180
35493933	272	279	patient	Species	9606
35493933	295	313	prion protein gene	Gene	5621
35493933	315	319	PRNP	Gene	5621
35493933	345	352	patient	Species	9606
35493933	445	469	[18F]-fluorodeoxyglucose	Chemical	MESH:D019788
35493933	500	509	[18F]-FDG	Chemical	MESH:D019788
35493933	524	550	[18F]-dihydrotetrabenazine	Chemical	-
35493933	581	591	[18F]-DTBZ	Chemical	MESH:C549477
35493933	670	678	dopamine	Chemical	MESH:D004298
35493933	711	718	patient	Species	9606
35493933	860	863	man	Species	
35493933	901	918	motor dysfunction	Disease	MESH:D000068079
35493933	972	976	FTDP	Disease	MESH:D057180
35493933	1032	1065	valine to isoleucine at codon 180	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
35493933	1069	1073	PRNP	Gene	5621
35493933	1102	1109	patient	Species	9606
35493933	1306	1315	[18F]-FDG	Chemical	MESH:D019788
35493933	1385	1395	[18F]-DTBZ	Chemical	MESH:C549477
35493933	1537	1557	cognitive impairment	Disease	MESH:D003072
35493933	1561	1565	FTDP	Disease	MESH:D057180
35493933	1590	1602	parkinsonism	Disease	MESH:D010302
35493933	1606	1610	FTDP	Disease	MESH:D057180
35493933	1693	1697	PRNP	Gene	5621
35493933	1698	1703	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
35493933	Association	MESH:D010302	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
35493933	Association	MESH:D003072	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
35493933	Association	MESH:D019788	5621
35493933	Association	MESH:D057180	5621
35493933	Association	MESH:D057180	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
35493933	Association	MESH:D010302	5621
35493933	Association	MESH:D010302	5621
35493933	Association	MESH:D003072	5621
35493933	Association	MESH:D057180	5621

